Ads
related to: $35 asthma inhaler price
Search results
Results From The WOW.Com Content Network
Starting Saturday, the cost of inhalers will fall for many Americans, as new out-of-pocket price caps go into effect for the asthma medications from AstraZeneca and Boehringer Ingelheim.
Boehringer had also said it would cap out-of-pocket costs for its inhaler products for chronic lung disease and asthma to $35 per month, starting June 1. ... including inhalers to treat asthma and ...
(Reuters) - Boehringer Ingelheim will reduce out-of-pocket costs for the company's inhaler products for a chronic lung disease and asthma to $35 per month starting June 1, the German drugmaker ...
For premium support please call: 800-290-4726 more ways to reach us
The Affordable Insulin Now Act is a bill in the United States Congress intended to cap out-of-pocket insulin prices under private health insurance and Medicare at no more than $35 per month. [ 1 ] The bill was first introduced on February 25, 2022, by Representative Angie Craig ( D - MN ). [ 2 ]
Novartis set the price of Gleevec at US$2666 per patient per month; generic companies were selling their versions at US$177 to 266 per patient per month. [174] Novartis also initiated a program to assist patients who could not afford its version of the drug, concurrent with its product launch.
Ad
related to: $35 asthma inhaler pricegoodrx.com has been visited by 100K+ users in the past month